Sale!

DSE Gene Ehlers-Danlos Syndrome Musculocontractural Type 2 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The DSE Gene Ehlers-Danlos Syndrome Musculocontractural Type 2 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the DSE gene. These mutations are associated with Ehlers-Danlos Syndrome Musculocontractural Type 2 (EDS MC Type 2), a rare genetic disorder characterized by multiple systemic involvements. This includes skin hyperextensibility, abnormal wound healing, muscle contractures, and skeletal abnormalities. The test is crucial for individuals showing symptoms of the disorder or those with a family history, as it provides definitive genetic evidence of the condition. By conducting a thorough analysis of the DSE gene, healthcare professionals can make accurate diagnoses, enabling them to tailor management and treatment plans effectively for affected individuals. The test is priced at 4400 AED and is conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring high-quality, reliable results.

Description

DSE Gene Ehlers-Danlos Syndrome Musculocontractural Type 2 Genetic Test

Test Name: DSE Gene Ehlers-Danlos Syndrome Musculocontractural Type 2 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Osteology Dermatology Immunology Disorders

Doctor: Dermatologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for DSE Gene Ehlers-Danlos Syndrome, Musculocontractural Type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with DSE Gene Ehlers-Danlos Syndrome, Musculocontractural Type 2 NGS Genetic DNA Test gene DSE

Test Details: DSE Gene Ehlers-Danlos Syndrome, Musculocontractural Type 2 NGS Genetic Test is a genetic test that analyzes the DSE gene for mutations associated with Ehlers-Danlos Syndrome, Musculocontractural Type 2 (EDSMC2). EDSMC2 is a rare genetic disorder characterized by joint hypermobility, contractures (limited joint movement), muscle atrophy, and characteristic facial features. It is caused by mutations in the DSE gene, which provides instructions for producing an enzyme called dermatan sulfate epimerase. This enzyme plays a crucial role in the production of dermatan sulfate, a component of connective tissues such as skin, tendons, and cartilage.

The NGS (Next-Generation Sequencing) genetic test involves analyzing the DNA sequence of the DSE gene to identify any mutations or variations that may be present. This test helps in confirming a diagnosis of EDSMC2 and can also be used for carrier testing or prenatal diagnosis in families with a known DSE gene mutation. By identifying the specific genetic mutation causing EDSMC2, this test can help in providing a more accurate diagnosis, guiding appropriate medical management, and offering genetic counseling to affected individuals and their families.

Test Name	DSE Gene Ehlers-Danlos syndrome musculocontractural type 2 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Osteology Dermatology Immunology Disorders
Doctor	Dermatologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for DSE Gene Ehlers-Danlos syndrome, musculocontractural type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with DSE Gene Ehlers-Danlos syndrome, musculocontractural type 2 NGS Genetic DNA Test gene DSE
Test Details	DSE Gene Ehlers-Danlos syndrome, musculocontractural type 2 NGS Genetic Test is a genetic test that analyzes the DSE gene for mutations associated with Ehlers-Danlos syndrome, musculocontractural type 2 (EDSMC2). EDSMC2 is a rare genetic disorder characterized by joint hypermobility, contractures (limited joint movement), muscle atrophy, and characteristic facial features. It is caused by mutations in the DSE gene, which provides instructions for producing an enzyme called dermatan sulfate epimerase. This enzyme plays a crucial role in the production of dermatan sulfate, a component of connective tissues such as skin, tendons, and cartilage. The NGS (Next-Generation Sequencing) genetic test involves analyzing the DNA sequence of the DSE gene to identify any mutations or variations that may be present. This test helps in confirming a diagnosis of EDSMC2 and can also be used for carrier testing or prenatal diagnosis in families with a known DSE gene mutation. By identifying the specific genetic mutation causing EDSMC2, this test can help in providing a more accurate diagnosis, guiding appropriate medical management, and offering genetic counseling to affected individuals and their families.